SeamVad Ltd.

www.seamvad.com (under construction) ; medvest.co.uk/portfolio-seamvad-1

High-Tech Company

Ceased to Operate Q1/2017

Graduated from: VLVJ

TECH VERTICALS

Healthtech, Life Sciences, Medical Devices, MedTech

General Data

Sector	Medical Devices
Company Stage:	R&D
Established	2008
Number of Employees	5
Reg. Number:	abCDe

DESCRIPTION

SeamVad offers a comprehensive solution, aiming to set a new standard and revolutionizing the approach to vessel anastomosis without changing the basic clinical technique of anastomosis. The Company develops unique and smart connectors for blood vessel anastomosis, aims to tackle the major drawbacks of the old traditional suture surgical procedure and be part of the global trends of converting the most conservative surgeon from manual suturing to suturless devices. The company solutions are in align with the accelerating demand for minimally invasive surgical procedures and are integrated with the upcoming surgery robotics solutions.

TECHNOLOGY

SeamVad's Automated Vascular Device includes two elements - introducer plus connector. The connector is based on bio-compatible materials with state-of the-art specific design technique. This solution can achieved remarkable clinical benefits such as: symmetrical attach of both vessel ends preventing any blood leaking, leaving optimal vessel diameter at the anastomosis site while not interfering with the blood flow. Our device is transparent to all known diagnosis technologies (such as X- Ray, M.R.I, Duplex – US and Doppler) which enable convenient imaging of blood flow through the anastomosis. The device enables intraluminal balloon dilatation and stenting procedures as well, due to its increasable diameter. Once increased (under the balloon pressure), the device keeps its new diameter firmly preventing any collapse at the conclusion of balloon dilation procedure. Installing SeamVad's device is easily achieved with its designated introducer

Products and Phases

Product	Phase
N/A
Automatically vascular connector and applicator device.

	TARGET MARKETS
	Peripheral Vascular Anastomosis Market, Clinics, Hospitals, Surgeons, Healthcare Providers, Hospitals

	BUSINESS MODEL
	B2B

REMARKS

Date	Remark
	Joined the Incubator on 07/2009.

CONTACT INFO

Expand / Collapse All

Main Address: Jerusalem, Israel

Address	High-Tech Village, Givat Ram Campus, The Hebrew University
POB	39158
City	Jerusalem
Country	Israel
Zip	91391

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. David Akunis	Co-Founder	Flometrica (CEO)

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Series A

Feb. 01, 2011

R&D

abCDe

Seed - Extended

Jul. 02, 2009

Seed

abCDe

Seed

Feb. 01, 2008

Seed

abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jul. 02, 2009

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe